S100PBP

Across TCGA pan-cancer cohorts, S100PBP Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated S100PBP data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher S100PBP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated S100PBP expression acts as an unfavorable survival marker.

LUAD, UCEC, and SKCM are the cancer types where S100PBP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.326	0.753	.013	27	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	OS	Median	All	0.113	0.323	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

S100PBP–LUAD (OS)

Open the LUAD breakdown →